Skip to main navigation Skip to search Skip to main content

Study to Evaluate the Safety, Tolerability, Immunogenicity & Efficacy in Preventing Vulvovaginal Candidiasis Following Administration of a Single Dose of NDV-3A Vaccine, NDV-3 Vaccine or Placebo

SUNY Downstate Health Sciences University

Project: Research

Project Details

StatusFinished
Effective start/end date09/13/13 → 09/12/17

Funding

  • NovaDigm Therapeutics Incorporated: $100,801.59